Former FDA leaders, pharma speak out on mifepristone

• by Theresa Gaffney

• May 8, 2026

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

• by Associated Press

• May 4, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

• by Kathryn Wighton

• May 6, 2026

• 4 min